BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 23664118)

  • 21. Molecular characterization of β1,4-galactosyltransferase 7 genetic mutations linked to the progeroid form of Ehlers-Danlos syndrome (EDS).
    Bui C; Talhaoui I; Chabel M; Mulliert G; Coughtrie MW; Ouzzine M; Fournel-Gigleux S
    FEBS Lett; 2010 Sep; 584(18):3962-8. PubMed ID: 20691685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deficiency of the core proteins of dermatan sulphate proteoglycans in a variant form of Ehlers-Danlos syndrome.
    Fushimi H; Kameyama M; Shinkai H
    J Intern Med; 1989 Dec; 226(6):409-16. PubMed ID: 2562251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biallelic COL3A1 mutations result in a clinical spectrum of specific structural brain anomalies and connective tissue abnormalities.
    Horn D; Siebert E; Seidel U; Rost I; Mayer K; Abou Jamra R; Mitter D; Kornak U
    Am J Med Genet A; 2017 Sep; 173(9):2534-2538. PubMed ID: 28742248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bi-allelic Alterations in AEBP1 Lead to Defective Collagen Assembly and Connective Tissue Structure Resulting in a Variant of Ehlers-Danlos Syndrome.
    Blackburn PR; Xu Z; Tumelty KE; Zhao RW; Monis WJ; Harris KG; Gass JM; Cousin MA; Boczek NJ; Mitkov MV; Cappel MA; Francomano CA; Parisi JE; Klee EW; Faqeih E; Alkuraya FS; Layne MD; McDonnell NB; Atwal PS
    Am J Hum Genet; 2018 Apr; 102(4):696-705. PubMed ID: 29606302
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Delbaere S; De Clercq A; Mizumoto S; Noborn F; Bek JW; Alluyn L; Gistelinck C; Syx D; Salmon PL; Coucke PJ; Larson G; Yamada S; Willaert A; Malfait F
    Front Cell Dev Biol; 2020; 8():597857. PubMed ID: 33363150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Musculocontractural Ehlers-Danlos Syndrome (former EDS type VIB) and adducted thumb clubfoot syndrome (ATCS) represent a single clinical entity caused by mutations in the dermatan-4-sulfotransferase 1 encoding CHST14 gene.
    Malfait F; Syx D; Vlummens P; Symoens S; Nampoothiri S; Hermanns-Lê T; Van Laer L; De Paepe A
    Hum Mutat; 2010 Nov; 31(11):1233-9. PubMed ID: 20842734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of dermatan sulfate epimerase (DSE) function results in musculocontractural Ehlers-Danlos syndrome.
    Müller T; Mizumoto S; Suresh I; Komatsu Y; Vodopiutz J; Dundar M; Straub V; Lingenhel A; Melmer A; Lechner S; Zschocke J; Sugahara K; Janecke AR
    Hum Mol Genet; 2013 Sep; 22(18):3761-72. PubMed ID: 23704329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypomorphic zebrafish models mimic the musculoskeletal phenotype of β4GalT7-deficient Ehlers-Danlos syndrome.
    Delbaere S; Van Damme T; Syx D; Symoens S; Coucke P; Willaert A; Malfait F
    Matrix Biol; 2020 Jul; 89():59-75. PubMed ID: 31862401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycosaminoglycan linkage region of urinary bikunin as a potentially useful biomarker for β3GalT6-deficient spondylodysplastic Ehlers-Danlos syndrome.
    Nikpour M; Noborn F; Nilsson J; Van Damme T; Kaye O; Syx D; Malfait F; Larson G
    JIMD Rep; 2022 Sep; 63(5):462-467. PubMed ID: 36101818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in FKBP14 cause a variant of Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss.
    Baumann M; Giunta C; Krabichler B; Rüschendorf F; Zoppi N; Colombi M; Bittner RE; Quijano-Roy S; Muntoni F; Cirak S; Schreiber G; Zou Y; Hu Y; Romero NB; Carlier RY; Amberger A; Deutschmann A; Straub V; Rohrbach M; Steinmann B; Rostásy K; Karall D; Bönnemann CG; Zschocke J; Fauth C
    Am J Hum Genet; 2012 Feb; 90(2):201-16. PubMed ID: 22265013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic defects in proteoglycan biosynthesis.
    Quentin-Hoffmann E; Harrach B; Robenek H; Kresse H
    Padiatr Padol; 1993; 28(1):37-41. PubMed ID: 8446427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spondyloepimetaphyseal dysplasia with joint laxity (Beighton type); mutation analysis in eight affected South African families.
    Vorster AA; Beighton P; Ramesar RS
    Clin Genet; 2015 May; 87(5):492-5. PubMed ID: 24766538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Redefining the progeroid form of Ehlers-Danlos syndrome: report of the fourth patient with B4GALT7 deficiency and review of the literature.
    Guo MH; Stoler J; Lui J; Nilsson O; Bianchi DW; Hirschhorn JN; Dauber A
    Am J Med Genet A; 2013 Oct; 161A(10):2519-27. PubMed ID: 23956117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defect in dermatan sulfate in urine of patients with Ehlers-Danlos syndrome caused by a CHST14/D4ST1 deficiency.
    Mizumoto S; Kosho T; Hatamochi A; Honda T; Yamaguchi T; Okamoto N; Miyake N; Yamada S; Sugahara K
    Clin Biochem; 2017 Aug; 50(12):670-677. PubMed ID: 28238810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathophysiological Significance of Dermatan Sulfate Proteoglycans Revealed by Human Genetic Disorders.
    Mizumoto S; Kosho T; Yamada S; Sugahara K
    Pharmaceuticals (Basel); 2017 Mar; 10(2):. PubMed ID: 28346368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Specific Role of Dermatan Sulfate as an Instructive Glycosaminoglycan in Tissue Development.
    Mizumoto S; Yamada S
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The first case report of Kyphoscoliotic Ehlers-Danlos syndrome of chinese origin with a novel PLOD1 gene mutation.
    Ni X; Jin C; Jiang Y; Wang O; Li M; Xing X; Xia W
    BMC Med Genet; 2020 Oct; 21(1):214. PubMed ID: 33129265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CHST14/D4ST1 deficiency: New form of Ehlers-Danlos syndrome.
    Kosho T
    Pediatr Int; 2016 Feb; 58(2):88-99. PubMed ID: 26646600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and pathophysiological delineation of musculocontractural Ehlers-Danlos syndrome caused by dermatan sulfate epimerase deficiency (mcEDS-DSE): A detailed and comprehensive glycobiological and pathological investigation in a novel patient.
    Minatogawa M; Hirose T; Mizumoto S; Yamaguchi T; Nagae C; Taki M; Yamada S; Watanabe T; Kosho T
    Hum Mutat; 2022 Dec; 43(12):1829-1836. PubMed ID: 35842784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expanding the clinical and mutational spectrum of B4GALT7-spondylodysplastic Ehlers-Danlos syndrome.
    Ritelli M; Dordoni C; Cinquina V; Venturini M; Calzavara-Pinton P; Colombi M
    Orphanet J Rare Dis; 2017 Sep; 12(1):153. PubMed ID: 28882145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.